|
 |
Thyrotropin AlfaThis page contains recent news articles, when available, and an overview of Thyrotropin Alfa but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Thyrotropin Alfa (when available) Binding of thyrotropin alfa to TSH receptors on normal thyroid epithelial cells or on well-differentiated thyroid cancer tissue stimulates iodine uptake and organification. Thyrogen is an exogenous source of human TSH that offers an additional diagnostic tool in the follow-up of patients with a history of well-differentiated thyroid cancer. For detection of residueal or recurrent thyroid cancer Mechanism Of Action: Binds to the thyrotropin receptors found on any residual thyroid cells or tissues. This stimulates radioactive iodine uptake for better radiodiagnostic imaging. News Articles on Thyrotropin Alfa Genzyme Reports Strong Second-Quarter Growth - Jul 23, 2008 Sales of Thyrogen(R) (thyrotropin alfa for injection) remained strong, increasing 34 percent to $39.4 million from $29.5 million. FOXBusiness No relief for cancer patients—drugs still cost more in India - Jun 27, 2008 But, so far only thyrotropin alfa injection has been notified. In the case of the exemptions and reductions announced in 2007, notifications have been Livemint, Genzyme Reports Strong First-Quarter Growth - 23 Apr 2008 Sales of Thyrogen(R) (thyrotropin alfa for injection) grew 28 percent in the first quarter to $33.8 million from $26.3 million, reflecting ongoing PR Newswire (press release), Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year - Feb 14, 2008 ...and Elaprase® (idursulfase) in Japan - and secured expanded US labeling for Campath® (alemtuzumab) and Thyrogen® (thyrotropin alfa for injection). Lifescience-online, Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year - Feb 13, 2008 ...and Elaprase(R) (idursulfase) in Japan-and secured expanded US labeling for Campath(R) (alemtuzumab) and Thyrogen(R) (thyrotropin alfa for injection). PR Newswire (press release), Genzyme Reports Strong Earnings Growth in Third Quarter - Oct 24, 2007 Sales of Thyrogen(R) (thyrotropin alfa for injection) grew 20 percent in the third quarter to $26.8 million, compared with $22.4 million in the period a CNNMoney.com Genzyme Begins Major Expansion of Boston Manufacturing Facility - Sep 18, 2007 ...and Thyrogen(R) (thyrotropin alfa for injection), used in the screening of patients who have had thyroid cancer. Genzyme last expanded the site in 2004. CNNMoney.com Genzyme expands flagship facility - Sep 18, 2007 Aldurazyme (laronidase) for MPS I disease and Thyrogen (thyrotropin alfa for injection) used in the screening of patients who have thyroid cancer, US-PharmaTechnologist.com, Genzyme Reports Significant Earnings Growth in Second Quarter - Jul 25, 2007 CNNMoney.comSales of Thyrogen(R) (thyrotropin alfa for injection) grew 25 percent in the second quarter to $29.5 million, compared with $23.7 million in the period a Genzyme Reports Significant Revenue and Earnings Growth in First ... - Apr 25, 2007 WebWire (press release),Also within the Therapeutics area, sales of Thyrogen® (thyrotropin alfa for injection) grew 15 percent to $26.3 million compared with $23.0 million in the Genzyme Reports Significant Revenue and Earnings Growth in First ... - 26 Apr 2007 WebWire (press release),Also within the Therapeutics area, sales of Thyrogen® (thyrotropin alfa for injection) grew 15 percent to $26.3 million compared with $23.0 million in the Genzyme Reports Strong Third-Quarter Financial Results Oct 12, 2006 Sales of Thyrogen® (thyrotropin alfa for injection) rose to $22.4 million in the second quarter, a 21 percent increase from sales of $18.5 million during the ... -Yahoo! News (press release) Genzyme Reports Strong Third-Quarter Financial Results Oct 12, 2006 Sales of Thyrogen(R) (thyrotropin alfa for injection) rose to $22.4 million in the second quarter, a 21 percent increase from sales of $18.5 million during the ... -Drug Newswire (press release), Thyrotropin Alfa Provides Equal or Improved Quality of Life to ... Jun 29, 2006 2006 -- Patients with chemotherapy-induced anemia demonstrated that recombinant human thyrotropin (rhTSH) -- also known as thyrotropin alfa -- provides equal ... -DG News Delivers Solid Earnings Growth Based on Strong Top-Line ... Jul 18, 2006 Sales of Thyrogen® (thyrotropin alfa for injection) rose to $23.7 million in the second quarter, a 15 percent increase from sales of $20.7 million during the ... -Oxfordshire Bioscience Network Genzyme Reports Second-Quarter Financial Results Jul 12, 2006 Sales of Thyrogen(R) (thyrotropin alfa for injection) rose to $23.7 million in the second quarter, a 15 percent increase from sales of $20.7 million during the ... -Drug Newswire Genzyme Reports Financial Results for the First Quarter of 2006 Apr 19, 2006 Sales of Thyrogen(R) (thyrotropin alfa for injection) increased 30 percent to $23 million in the first quarter, up from $17.7 million a year earlier. ... - MSN Money Genzyme Granted Label Change for Thyrogen Feb 1, 2006 ...today announced that the US Food and Drug Administration (FDA) has authorized a label modification for Thyrogen® (thyrotropin alfa for injection) to reflect ... - DG News Brand Names/Synonyms: Thyrotropin Alfa is also known by the following brand names and/or synonymsFollitropin beta chain precursor;Follicle-stimulating hormone beta subunit;FSH-beta;FSH-B; Thyrogen (Genzyme Inc) Drug Category: Thyrotropin Alfa is categorized under the following by the FDA: Diagnostic Agents; thyroid function (36:60.00) Dosage Forms: POWDER FOR SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human alpha thyrotropin : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |